These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28663207)

  • 1. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem.
    Andrews SF; Graham BS; Mascola JR; McDermott AB
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outflanking immunodominance to target subdominant broadly neutralizing epitopes.
    Angeletti D; Kosik I; Santos JJS; Yewdell WT; Boudreau CM; Mallajosyula VVA; Mankowski MC; Chambers M; Prabhakaran M; Hickman HD; McDermott AB; Alter G; Chaudhuri J; Yewdell JW
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13474-13479. PubMed ID: 31213541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine.
    Crowe JE
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development.
    Khanna M; Sharma S; Kumar B; Rajput R
    Biomed Res Int; 2014; 2014():546274. PubMed ID: 24982895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    Wang W; Vassell R; Song HS; Chen Q; Keller PW; Verma S; Alvarado-Facundo E; Wan H; Schmeisser F; Meseda CA; Weir JP; Weiss CD
    PLoS One; 2019; 14(9):e0222436. PubMed ID: 31513662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
    Neu KE; Henry Dunand CJ; Wilson PC
    Curr Opin Immunol; 2016 Oct; 42():48-55. PubMed ID: 27268395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
    Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
    mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
    Andrews SF; Cominsky LY; Shimberg GD; Gillespie RA; Gorman J; Raab JE; Brand J; Creanga A; Gajjala SR; Narpala S; Cheung CSF; Harris DR; Zhou T; Gordon I; Holman L; Mendoza F; Houser KV; Chen GL; Mascola JR; Graham BS; Kwong PD; Widge A; Dropulic LK; Ledgerwood JE; Kanekiyo M; McDermott AB
    Sci Transl Med; 2023 Apr; 15(692):eade4976. PubMed ID: 37075126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.